FINWIRES · TerminalLIVE
FINWIRES

ASX Issues Fiscal Year 2027 Expense Growth Guidance, Raises Capex Outlook; Shares Fall 12%

By

ASX (ASX:ASX) said it expects fiscal year 2027 expenses to grow between 18% and 21% from fiscal year 2026, while operating expenses excluding depreciation and amortization are forecast to rise 13% to 16%, according to a Tuesday filing with the Australian bourse.

The company said the forecast for higher expenses is mainly driven by technology modernization, and changes it is making in response to an inquiry by the Australian Securities and Investments Commission that flagged certain governance and risk management failures.

ASX increased its fiscal year 2027 capital expenditure guidance to between AU$180 million and AU$200 million from a previous range of AU$160 million to AU$180 million, primarily driven by technology cost inflation and new product development. The company also disclosed fiscal year 2028 capital expenditure guidance of between AU$170 million and AU$190 million.

Additionally, ASX adjusted its medium-term target range for underlying return on equity to between 12% and 14% from a previous target of 12.5% to 14%. The company kept its dividend policy intact with a payout ratio range of 75% to 85% of underlying net profit after tax.

Meanwhile, the stock exchange operator struck a deal to sell its 49% stake in Sympli to its joint venture partner, ATI Group, for a nominal amount. The sale will result in an after-tax loss of about AU$12 million in fiscal year 2026.

ASX shares fell 12% in recent Tuesday trade.

Related Articles

Asia

Infratil Cuts Stake in Contact Energy

Contact Energy (ASX:CEN, NZE:CEN) said the stake of Infratil (ASX:IFT) and Infratil Investments in the firm fell to 9.081% as of Monday from 14.081% previously, according to same-day filings with the Australian and New Zealand bourses.Infratil Investments signed a deal with Macquarie Securities (NZ), under which Infratil Investments appointed Macquarie Securities to underwrite, sell, and manage the disposal of 53.5 million ordinary shares in the firm held by Infratil Investments. The shares were allocated to investors at a sale price of NZ$9.25 per ordinary share.Infratil now holds 97.2 million shares of the firm.Contact Energy's shares rose nearly 1% in recent trading on Monday.

ASX:CENASX:IFTNZE:CEN
Asia

Update: Market Chatter: National Australia Bank Plans to Hire Over 1,000 Employees in India, Vietnam

(Updates with comments from National Australia Bank in the last two paragraphs.)National Australia Bank (ASX:NAB) intends to hire over 1,000 additional employees in India and Vietnam following a doubling of its headcount in both countries over the last three years, the Australian Financial Review reported Monday, citing an anonymous source inside the bank.The company has roughly 5,000 staff in India and around 2,000 in Vietnam, representing about 18% of its total workforce, according to the report.The reported overseas hiring plans come amid tensions over Australian banks reducing their domestic headcount."The notion that Australia lacks enough skilled workers, especially in technology and engineering, is laughable, given these are the exact types of jobs being targeted in sweeping job cuts happening across the finance sector as we speak," AFR cited Finance Sector Union national assistant secretary Nicole McPherson as saying.In a statement to, National Australia Bank said its overall workforce in Australia has increased over the last five years, while some of the growth in Asia is due to "insourcing capability that NAB had previously outsourced over a number of years.""Our workforce continues to evolve to ensure we can help customers more consistently at the times they need us, and to help us access great talent in key markets," the bank said.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

ASX:NAB
Asia

Australian Clinical Labs Says Commonwealth Bank Stake Rises

Australian Clinical Labs (ASX:ACL) said the Commonwealth Bank of Australia's (ASX:CBA) voting power in the company rose to 8.31% from 7.29% as of May 22, according to a Monday Australian bourse filing.The bank now holds 15.6 million ordinary shares of the firm.

ASX:ACLASX:CBA